BC
Broadfin Capital Portfolio holdings
AUM
$403M
This Quarter Return
+17.34%
1 Year Return
+74.97%
3 Year Return
+245.63%
5 Year Return
+336.04%
10 Year Return
–
AUM
$595M
AUM Growth
+$595M
(-6.1%)
Cap. Flow
-$69.7M
Cap. Flow
% of AUM
-11.72%
Top 10 Holdings %
Top 10 Hldgs %
56.53%
Holding
64
New
13
Increased
8
Reduced
12
Closed
23
Top Buys
| 1 |
Iovance Biotherapeutics
IOVA
|
$41.4M |
| 2 |
ENDP
Endo International plc
ENDP
|
$24.4M |
| 3 |
Exact Sciences
EXAS
|
$15.6M |
| 4 |
Tandem Diabetes Care
TNDM
|
$12.6M |
| 5 |
Dentsply Sirona
XRAY
|
$11.5M |
Top Sells
Sector Composition
| 1 | Healthcare | 89.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Iovance Biotherapeutics
IOVA
$807M
| $53.1M | 8.36% | 4,146,605 +3,233,618 | +354% | +$41.4M |
|
|
MRTX
2
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $50.3M | 7.92% | 1,020,178 -423,770 | -29% | -$20.9M |
|
|
LJPC
3
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $43.6M | 6.86% | 1,494,520 -162,200 | -10% | -$4.73M |
|
|
ADMS
4
DELISTED
Adamas Pharmaceuticals, Inc.
ADMS
| $36.6M | 5.76% | 1,417,121 +281,918 | +25% | +$7.28M |
|
|
CORI
5
DELISTED
Corium International, Inc.
CORI
| $28.8M | 4.54% | 3,597,057 +477,412 | +15% | +$3.82M |
|
6
Travere Therapeutics
TVTX
$1.56B
| $28.6M | 4.5% | 1,048,693 -129,533 | -11% | -$3.53M |
|
|
ZGNX
7
DELISTED
Zogenix, Inc.
ZGNX
| $27.5M | 4.33% | 622,380 +85,000 | +16% | +$3.76M |
|
|
ENDP
8
DELISTED
Endo International plc
ENDP
| $24.4M | 3.85% | +2,591,573 | New | +$24.4M |
|
|
HZNP
9
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $22.2M | 3.49% | 1,339,575 -1,224,600 | -48% | -$20.3M |
|
10
Catalyst Pharmaceutical
CPRX
$2.52B
| $21.1M | 3.33% | 6,772,764 -40,000 | -0.6% | -$125K |
|
11
Heron Therapeutics
HRTX
$207M
| $20.2M | 3.18% | 519,787 -1,061,629 | -67% | -$41.2M |
|
|
PETX
12
DELISTED
Aratana Therapeutics, Inc.
PETX
| $18.3M | 2.87% | 4,294,426 | – | – |
|
|
AVDL
13
Avadel Pharmaceuticals
AVDL
$1.43B
| $16.7M | 2.63% | 2,724,663 +100,000 | +4% | +$613K |
|
|
14
Exact Sciences
EXAS
$8.98B
| $15.6M | 2.46% | +261,400 | New | +$15.6M |
|
15
ADMA Biologics
ADMA
$4.12B
| $14.7M | 2.31% | 3,249,829 +2,529,300 | +351% | +$11.4M |
|
|
SBBP
16
DELISTED
Strongbridge Biopharma plc.
SBBP
| $14M | 2.21% | 2,340,649 -453,103 | -16% | -$2.72M |
|
|
BDSI
17
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $12.6M | 1.99% | 4,278,819 | – | – |
|
|
18
Tandem Diabetes Care
TNDM
$845M
| $12.6M | 1.98% | +570,598 | New | +$12.6M |
|
|
ATRS
19
DELISTED
Antares Pharma, Inc.
ATRS
| $11.9M | 1.88% | 4,623,247 -50,000 | -1% | -$129K |
|
|
20
Dentsply Sirona
XRAY
$2.85B
| $11.5M | 1.81% | +262,900 | New | +$11.5M |
|
21
Integra LifeSciences
IART
$1.18B
| $10.5M | 1.66% | 163,424 -135,000 | -45% | -$8.7M |
|
|
TLGT
22
DELISTED
Teligent, Inc
TLGT
| $10.4M | 1.63% | 2,999,817 +1,309,023 | +77% | +$4.53M |
|
|
SCTL
23
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
| $10.3M | 1.62% | 2,048,025 -188,000 | -8% | -$944K |
|
24
KALA BIO
KALA
$78.8M
| $8.22M | 1.29% | 598,586 -82,653 | -12% | -$1.13M |
|
25
LivaNova
LIVN
$3.08B
| $7.2M | 1.13% | +72,100 | New | +$7.2M |
|